Eligibility policies for the state AIDS drug assistance programs.
Drug treatments for HIV infection and related opportunistic infections have had dramatic impacts on the morbidity and mortality associated with HIV disease. HIV drug therapies are essential to the survival and to improved quality of life for individuals with HIV. However, not all people with HIV disease are receiving these medications. The state AIDS drug assistance programs (ADAPs) can provide access to drug therapies for many people with HIV disease who lack adequate drug coverage. This research presents the results of a national survey that identified eligibility-related policies implemented by .48 state ADAPs during 1998 and 1999. The survey assessed the number of people receiving ADAP coverage, the percentage of ADAP beneficiaries who are women, financial and medical eligibility requirements, characteristics of the application process, any implementation of waiting lists, and any coordination of the ADAPs with other public programs.
Buchanan
R J
RJ
Department of Health Policy and Management, School of Rural Public Health, The Texas A&M University System Health Science Center, College Station 77843-1266, USA. buchanan@medicine.tamu.edu
Chakravorty
B J
BJ
Smith
S R
SR
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000191:economics; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000191:economics*; D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics; D019090:Case Management; D004608:Eligibility Determination / Q000331:legislation & jurisprudence*; D019538:Health Care Surveys; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D008483:Medical Assistance / Q000331:legislation & jurisprudence*; D013221:State Health Plans / Q000191:economics* / Q000331:legislation & jurisprudence; D011795:Surveys and Questionnaires; D014481:United States
D019380:Anti-HIV Agents